Apr 22, 2021 03:16 PM EDT
Scientists all over the country are testing a new two-dose COVID-19 vaccine candidate that is based on plants. Produced by Medicago vaccination, a biopharmaceutical company in Canada, the shot makes use of tobacco shrub to manufacture coronavirus-like particles.They help the body to be aware of the pathogen so that it can bring about an immune response and set an attack in motion if a person becomes infected.
(Photo : Getty Images)
Virus-like Particles (VLPs).
If the late-stage clinical trial confirms the candidate is successful, it could be quicker and less expensive to make - and easier distribution - than other vaccines that are available.
Canada
North-carolina
United-states
Nebraska
Raleigh
Matthew-hong
Mark-carlson
Centers-for-disease
Drug-administration
Johnson
Wake-research-in-raleigh
Getty-images